Your browser doesn't support javascript.
loading
An assessment of the minimal clinically important difference for the pain disability quality-of-Life Questionnaire-Spine.
Amatto, Alycia; Smith, Ashley; Pan, Bo; Al Hamarneh, Yazid; Burnham, Taylor; Burnham, Robert.
  • Amatto A; Division of Physical Medicine and Rehabilitation, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
  • Smith A; Vivo Cura Health, Calgary, Alberta, Canada.
  • Pan B; Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Al Hamarneh Y; Epicore Centre & Alberta SPOR Support Unit, Consultation & Research Services, University of Alberta, Edmonton, Alberta, Canada.
  • Burnham T; Epicore Centre & Alberta SPOR Support Unit, Consultation & Research Services, University of Alberta, Edmonton, Alberta, Canada.
  • Burnham R; University of Utah, Department of Physical Medicine and Rehabilitation, Salt Lake City, UT, USA.
Interv Pain Med ; 1(3): 100116, 2022 Sep.
Article en En | MEDLINE | ID: mdl-39238520
ABSTRACT

Objective:

The Pain Disability Quality-Of-Life Questionnaire-Spine (PDQQ-S) is a validated six question patient reported outcome measure designed for usage in minimally invasive spine intervention. The purpose of this study was to determine the Minimal Clinically Important Difference (MCID) for the PDQQ-S.

Design:

Retrospective single arm cohort study involving 411 patients who had undergone lumbar facet and/or sacroiliac joint RFN and had completed pre-and 3-month post RFN PDQQ-S.

Methods:

The MCID using both distribution and anchor-based ("Rebook RFN"; "Analgesic Requirements") methods were calculated.

Results:

The distribution-based approach (using standard error of measurement) estimated the MCID to be -17.3 [PDQQ-S baseline mean (SD) 46.9 (7.9)]. This is supported by the anchor based approach, which calculated the MCID to be -21.5 for rebook RFN; -11.3, -17.2 and -30.5 for mildly, moderately and dramatically decreased NSAID use respectively; and -11.7, -16.9 and -31.7 for mildly, moderately and dramatically decreased opioid use respectively. A moderate reduction in medication use was deemed to be clinically relevant.

Conclusion:

The MCID value for the PDQQ-S is a score reduction of 17.
Palabras clave